Shreekrishna Biotech has informed that at the Meeting of the Board of Directors of the Company held on December 16, 2013 and the approval of the shareholders on meeting held on September 05, 2013 it has been decided to allot 10,000,000 Convertible Warrants on preferential basis to other than promoter.
The above information is a part of company’s filings submitted to BSE.